Matinas BioPharma Holdings, Inc.
AMEX: MTNB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange American
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jerome D. Jabbour
- Employees
- 3
- Headquarters
- Bedminster, United States
- IPO year
- 2014
- Market cap
- $3.4M
- Website
- https://www.matinasbiopharma.com
Loading MTNB…
Loading profile data…Frequently asked questions about MTNB
What does Matinas BioPharma Holdings, Inc. (MTNB) do?
Matinas BioPharma Holdings, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to identifying and advancing a range of potential therapeutic products. The company's innovative Lipid Nanocrystal (LNC) platform technology underpins its product development efforts. This sophisticated LNC delivery system leverages lipid na...
Where does MTNB trade?
Matinas BioPharma Holdings, Inc. (MTNB) trades on the New York Stock Exchange American.
What sector is MTNB in?
Matinas BioPharma Holdings, Inc. (MTNB) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Matinas BioPharma Holdings, Inc.?
Jerome D. Jabbour is the chief executive officer of Matinas BioPharma Holdings, Inc. (MTNB).
Where is Matinas BioPharma Holdings, Inc. headquartered?
Matinas BioPharma Holdings, Inc. is headquartered in United States.
Does MTNB pay a dividend?
Matinas BioPharma Holdings, Inc. (MTNB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MTNB go public?
Matinas BioPharma Holdings, Inc. (MTNB) completed its initial public offering in 2014.